home.aspx

 
.

LABEL-FREE TECHNIQUES FOR DRUG DISCOVERY: SURFACE PLASMON RESONANCE (SPR) AND MALDI MASS SPECTROMETRY FOR PRIMARY (HTS) AND SECONDARY SCREENING

SHARESHARESHARE
The webinar will update on latest developments in MALDI mass spectrometry for high-throughput screening and CPD profiling (rapifleX MALDI PharmaPulse) and introduce Bruker's new surface plasmon resonance (SPR) instrument, the SIERRA SPR-32. Beside technical details explaining the latest developments, synergies between MALDI mass spectrometry and SPR will be discussed.